Your session is about to expire
← Back to Search
MRI with Hyperpolarized Pyruvate for Advanced Prostate Cancer
Study Summary
This trial is testing whether a specific kind of MR imaging can help detect and track prostate cancer that has spread, including a type that is hard to treat.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to give informed consent due to my age, health, or mental condition.I have a detectable tumor suitable for a special MRI scan.I don't have a bleeding disorder and can safely pause any blood-thinning medications for a biopsy.My prostate cancer is advanced or has spread, confirmed by tests.I can follow the study's procedures and have signed the consent. I am mostly active.
- Group 1: Cohort A: Hyperpolarized C13 MRI at a single time point
- Group 2: Cohort B: Hyperpolarized C13 MRI at multiple time points
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants is this clinical trial accommodating?
"Affirmative. According to clinicaltrials.gov, this medical study is welcoming applicants as it was first published on July 16th 2020 and last updated on July 27th 2022. It aims to enrol 75 patients at one location."
Are there any openings left for participants in this investigation?
"As per clinicaltrials.gov this investigation is open for recruitment, having been initiated on July 16th 2020 and last revised on July 27th 2022."
Could you provide information on the safety of Hyperpolarized C13 for individuals being treated?
"Hyperpolarized C13 was deemed to have a score of 2 based on the evidence available. This is because, while there are some indications that it may be safe, no studies suggest its efficacy yet."
Share this study with friends
Copy Link
Messenger